Zhengye Biotechnology Holding Limited
ZYBT
$6.70
-$2.79-29.40%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.35M | 6.38M | 6.56M | 6.61M | 6.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.35M | 6.38M | 6.56M | 6.61M | 6.56M |
| Cost of Revenue | 3.71M | 3.73M | 2.88M | 2.91M | 3.12M |
| Gross Profit | 2.65M | 2.66M | 3.67M | 3.71M | 3.45M |
| SG&A Expenses | 2.03M | 2.04M | 2.27M | 2.29M | 1.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.25M | 6.28M | 5.53M | 5.57M | 5.48M |
| Operating Income | 106.10K | 106.70K | 1.03M | 1.04M | 1.08M |
| Income Before Tax | 77.20K | 77.60K | 917.10K | 925.10K | 1.14M |
| Income Tax Expenses | -113.60K | -114.10K | 176.60K | 178.20K | 207.60K |
| Earnings from Continuing Operations | 190.80K | 191.70K | 740.50K | 746.90K | 930.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -30.90K | -31.10K | -118.30K | -119.40K | -149.80K |
| Net Income | 159.90K | 160.60K | 622.20K | 627.60K | 780.90K |
| EBIT | 106.10K | 106.70K | 1.03M | 1.04M | 1.08M |
| EBITDA | 1.00M | 1.01M | 1.81M | 1.82M | 1.92M |
| EPS Basic | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 45.67M | 45.67M | 45.67M | 45.67M | 45.67M |
| Average Diluted Shares Outstanding | 45.67M | 45.67M | 45.67M | 45.67M | 45.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 7.17% | 7.17% | 175.98% | 175.98% | 190.24% |